GC1102

BIOLOGICAL3 trials

Sponsors

Green Cross Corporation

Conditions

Chronic Hepatitis BHepatitis B

Phase 1

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

CompletedNCT01606163

Green Cross CorporationHepatitis B

Start: 2012-08-31End: 2013-12-31Updated: 2014-01-03

A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

CompletedNCT02569372

Green Cross CorporationChronic Hepatitis B

Start: 2015-11-09End: 2017-10-12Updated: 2017-10-16

Phase 2

A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

Green Cross CorporationHepatitis B

Start: 2019-02-11End: 2021-12-31Updated: 2019-12-13